Registration on ClinicalTrials.gov is a requirement for all National Institutes of Health (NIH)-funded clinical trials and all Food and Drug Administration (FDA) “Applicable Clinical Trials." This ...

For unresectable or metastatic liver cancer, the TPST-1120-301 trial of amezalpat combination therapy has received a “Study ...

This clinical trial is a randomized, double-blind study designed to enroll 120 patients across four treatment groups. The primary endpoint will evaluate the difference in weight loss of nimacimab ...

Media ReleaseEfti in combination with pembrolizumab and radiotherapy demonstrates significant efficacy in the neoadjuvant setting in patients ...

The investigational treatment is currently being evaluated in a 3-part phase 1 trial (ClinicalTrials.gov Identifier: NCT05521022) in adult patients with systemic amyloidosis, as well as a phase 2 open ...

Our lead therapeutic candidate, IGC-AD1, is a cannabinoid-based treatment currently in a Phase 2 trial for agitation in ...

“The study is expected to be completed in the first quarter of next year according to clinicaltrials.gov and could provide ...

Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...

Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics ...

NKTR-255 in combination with durvalumab following chemoradiation was well-tolerated in patients with non–small cell lung ...